Cite
Progesterone receptor is a significant factor associated with clinical outcomes and effect of adjuvant tamoxifen therapy in breast cancer patients.
MLA
Liu, Shuzhen, et al. “Progesterone Receptor Is a Significant Factor Associated with Clinical Outcomes and Effect of Adjuvant Tamoxifen Therapy in Breast Cancer Patients.” Breast Cancer Research & Treatment, vol. 119, no. 1, Feb. 2010, pp. 53–61. EBSCOhost, https://doi.org/10.1007/s10549-009-0318-0.
APA
Liu, S., Chia, S., Mehl, E., Leung, S., Rajput, A., Cheang, M., & Nielsen, T. (2010). Progesterone receptor is a significant factor associated with clinical outcomes and effect of adjuvant tamoxifen therapy in breast cancer patients. Breast Cancer Research & Treatment, 119(1), 53–61. https://doi.org/10.1007/s10549-009-0318-0
Chicago
Liu, Shuzhen, Stephen Chia, Erika Mehl, Samuel Leung, Ashish Rajput, Maggie Cheang, and Torsten Nielsen. 2010. “Progesterone Receptor Is a Significant Factor Associated with Clinical Outcomes and Effect of Adjuvant Tamoxifen Therapy in Breast Cancer Patients.” Breast Cancer Research & Treatment 119 (1): 53–61. doi:10.1007/s10549-009-0318-0.